Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, health care giant Abbott Laboratories (ABT -0.20%) has earned a coveted five-star ranking.
With that in mind, let's take a closer look at Abbott and see what CAPS investors are saying about the stock right now.
Abbott facts
|
Headquarters (founded) |
Abbott Park, Ill. (1888) |
|
Market Cap |
$52.6 billion |
|
Industry |
Health care equipment |
|
Trailing-12-Month Revenue |
$39.4 billion |
|
Management |
Chairman/CEO Miles White (since 1999) |
|
Return on Equity (average, past 3 years) |
22.3% |
|
Cash/Debt |
$11.5 billion / $16.3 billion |
|
Dividend Yield |
0.9% |
|
Competitors |
Johnson & Johnson (JNJ 0.82%) |
Sources: S&P Capital IQ and Motley Fool CAPS.
On CAPS, 97% of the 2,658 members who have rated Abbott believe the stock will outperform the S&P 500 going forward.
A couple of months ago, one of those Fools, BuilderJS, succinctly summed up the Costco bull case for our community:
Compelling business model -- limited selection focused on value to the customer. Outstanding leadership and corporate culture that promotes business continuity. Excellent execution -- from the top notch merchandising, to the ability to negotiate with suppliers to the responsible growth plans.
Want to see how well (or not so well) the stocks in this series are performing? Follow the TrackPoisedTo CAPS account.
